全文获取类型
收费全文 | 224940篇 |
免费 | 20910篇 |
国内免费 | 8494篇 |
专业分类
耳鼻咽喉 | 1445篇 |
儿科学 | 5158篇 |
妇产科学 | 2900篇 |
基础医学 | 42954篇 |
口腔科学 | 5563篇 |
临床医学 | 14099篇 |
内科学 | 37534篇 |
皮肤病学 | 3642篇 |
神经病学 | 18652篇 |
特种医学 | 4177篇 |
外国民族医学 | 60篇 |
外科学 | 16960篇 |
综合类 | 27471篇 |
现状与发展 | 32篇 |
预防医学 | 10473篇 |
眼科学 | 2562篇 |
药学 | 30152篇 |
23篇 | |
中国医学 | 7657篇 |
肿瘤学 | 22830篇 |
出版年
2024年 | 573篇 |
2023年 | 3462篇 |
2022年 | 7589篇 |
2021年 | 9375篇 |
2020年 | 7698篇 |
2019年 | 8647篇 |
2018年 | 8199篇 |
2017年 | 8181篇 |
2016年 | 8013篇 |
2015年 | 9476篇 |
2014年 | 13347篇 |
2013年 | 15135篇 |
2012年 | 13763篇 |
2011年 | 16254篇 |
2010年 | 13661篇 |
2009年 | 12985篇 |
2008年 | 12429篇 |
2007年 | 11125篇 |
2006年 | 10026篇 |
2005年 | 8530篇 |
2004年 | 7510篇 |
2003年 | 6540篇 |
2002年 | 5031篇 |
2001年 | 4337篇 |
2000年 | 3552篇 |
1999年 | 3270篇 |
1998年 | 2798篇 |
1997年 | 2648篇 |
1996年 | 2216篇 |
1995年 | 1935篇 |
1994年 | 1668篇 |
1993年 | 1447篇 |
1992年 | 1219篇 |
1991年 | 1139篇 |
1990年 | 950篇 |
1989年 | 809篇 |
1988年 | 704篇 |
1987年 | 605篇 |
1986年 | 610篇 |
1985年 | 1057篇 |
1984年 | 1065篇 |
1983年 | 743篇 |
1982年 | 882篇 |
1981年 | 685篇 |
1980年 | 549篇 |
1979年 | 469篇 |
1978年 | 379篇 |
1977年 | 302篇 |
1976年 | 259篇 |
1975年 | 192篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
991.
C. NAPOLI A. LIGUORI P. SORICE A. DI BENEDETTO S. CIAFRE T. POSCA N. DI IESO F. P. D'ARMIENTO 《Journal of internal medicine》1996,240(6):389-394
Background. Arterial hypertension is a significant risk factor for the high rate of cardiovascular disease in chronic uraemic (CU) patients. Any role that hypertension may play in CU patient outcomes assumes added significance. The elevation of some hormonal factors in early clinical stage could represent a valuable marker of cardiac disease in CU. Aim. This study first investigated the role of several hormones on cardiac diastolic properties in CU patients. Moreover, the study investigated the association of hypertension with both diastolic function and release of vasoactive hormones in CU patients. Results. We have reported that the early impairment of diastolic function is correlated with the elevation of both circulating plasma atrial natriuretic factor and endothelin-1 (ET-1) in hypertensive CU patients. Since the effect of ET-1 on diastolic function is still poorly understood, we have investigated also this issue. In eight additional patients with reduced E/A ratio, but without uraemia, hypertension or chronic heart failure, we have showed a high inverse correlation between the values of E/A ratio and ET-1 plasma concentrations. Conclusions. These results strongly suggest that the elevation in ET-1 levels was correlated with diastolic dysfunction in man. This phenomenon may have important pathophysiological implications suggesting the possibility of an early therapeutic approach in these patients. 相似文献
992.
Alexey V. Mazurov Dimitry V. Vinogradov Svetlana G. Khaspekova Anatoly V. Krushinsky Ludmila V. Gerdeva Sergei A. Vasiliev 《European journal of haematology》1996,57(1):38-41
Abstract: Patient B.G. is a 29-yr-old female with a lifelong bleeding disorder characterized clinically by a highly increased bleeding time, menorrhagias, long-lasting bleeding after cuts and tooth extractions and large post-traumatic haematomas. Her coagulation tests were within normal range, platelet count was 140,000–160,000 per μl, but platelet function was impaired as demonstrated by the absence of collagen-induced aggregation, although no abnormalities were detected in aggregation response to ADP and ristocetin. Morphologically her platelets were characterized by gigantic size – average profile area was about 2.5 times higher than that of control donors, and severe deficiency of α-granules – only 16% of their number in control donors. These features taken together indicated the diagnosis of grey platelet syndrome. As has been shown by quantitative immunoblotting, patient's platelets contained small amounts of α-granule membrane protein P-selectin – about 15% of that in control donors. The content of plasma membrane glycoproteins IIb–IIIa and Ib was not reduced, suggesting the specific deficiency of α-granule membrane protein. Thus, B.G. is the second patient described in the literature (see also Lages et al, J Clin Invest 1991: 87: 919–929) with combined deficiency of α-granules and P-selectin. 相似文献
993.
C. Marie C. Mossiat C. Gros T. Monteil J. Bralet 《Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy》1996,10(5):593-598
Summary Myocardial infarction was induced in rats by ligation of the left coronary artery. Treatment with TM1, a prodrug of SQ 28,603, an inhibitor of neutral endopeptidase (NEP, EC 3.4.24.11), was started 18–20 hours after ligation and was continued for 4 weeks (100 mg/kg, orally, twice daily). Morphological and biochemical parameters were assessed at the end of therapy. The treatment resulted in a significant reduction of heart hypertrophy, which was restricted to the parts of myocardium hemodynamically upstream of the infarcted left ventricle. The weights of the right ventricle and atria were reduced by 15–20%, whereas the treatment had no effect on the left ventricle and septum weights. Treatment led to an almost complete inhibition of plasma NEP activity and to a slight decrease (-14%, p<0.05) in plasma ACE activity. Plasma ANF level increased 3.8-fold after ligation, and treatment resulted in a slight (+29%) and nonsignificant additional increase in the ANF level. The amount of hydroxyproline in the right ventricle was enhanced by +207% in control ligated rats and by +140% (NS) in treated rats. These data indicate that prolonged NEP inhibition exerts a favorable effect in heart failure by reducing the development of right ventricular and atrial hypertrophy. These effects may result from an improvement in hemodynamic conditions, leading to a reduction in cardiac preload. 相似文献
994.
Stefan Somlo 《Clinical and experimental nephrology》1998,2(3):211-217
Conclusion The past decade has seen extraordinary progress in the study of autosomal-dominant polycystic kidney disease. The 2 major
genes for this disorder have been identified. Animal models of ADPKD have been produced. The molecular basis of the disease
has been characterized. ADPKD is a “second-hit” disease, much like many cancer predisposition syndromes. This has profound
implications for our understanding. The progression of ADPKD in individual patients is likely related more to their individual
rate of acquisition of second hits at thePKD1 orPKD2 locus than to the inherited germ line mutation itself. Therapeutic approaches will perhaps now be considered, which will
include interventions that may limit the rate at which somatic mutations occur in the kidney. The major focus of research
at present is to elucidate the normal functions ofPKD1 andPKD2. Protein binding partners are being sought for both proteins. The possible calcium channel function ofPKD2 is being investigated. The downstream effects of cellular deficiency of either protein are likely to yield many clues. Modifying
genetic factors that may independently affect disease progression are likely to be identified using the several mouse models.
Perhaps the next decade will bring great strides in understanding and in potential therapy for this common disease.
This paper was presented at the 2nd International Forum “The Frontiers of Nephrology,” Tokyo, May 10, 1998. 相似文献
995.
Metabotropic Glutamate Receptors Inhibiting Excitatory Synapses in the CA1 Area of Rat Hippocampus 总被引:2,自引:0,他引:2
In the CA1 region of hippocampal slices prepared from young adult rats, we studied the ability of several specific agonists of metabotropic glutamate receptors (mGluRs) to depress excitatory synaptic transmission at the CA3–CA1 pyramidal cell synapses. Three groups of mGluRs have been described: group 1 (mGluR1 and 5) receptors are positively coupled to phospholipase C whereas group 2 (mGluR2 and 3) and group 3 (mGluR4, 6, 7 and 8) receptors are negatively coupled to adenylate cyclase. We found that the broad-spectrum agonist (1 S ,3R)-1-aminocyclopentyl-1,3-dicarboxylate and the group 1-specific agonist ( R,S )-dihydroxyphenylglycine both reversibly inhibited evoked field excitatory postsynaptic potentials, indicating the involvement of group 1 mGluRs. ( R,S )-3,5-dihydroxyphenylglycine presumably inhibited transmission via a presynaptic mechanism, as whole-cell voltage-clamp recordings revealed that inhibition of the synaptic transmission was always accompanied with an increase in paired-pulse facilitation. Treatment with a specific blocker of mGluR1 receptors, the phenylglycine derivative ( S )-4-carboxyphenylglycine, was without effect on the (1 S ,3 R )-1-amino-cyclopentyl-1,3-dicarboxylate-induced depression of the field excitatory postsynaptic potentials, strongly suggesting that mGluR5 receptors are responsible for the (1 S ,3 R )-1-aminocyclopentyl-1,3-dicarboxylate effect. Two selective agonists of group 2 mGluRs, (2 S ,1' s ,2' s )-2-(2'-carboxycyclopropyl)glycine and 4-carboxy-3-hydroxyphenylglycine, were totally ineffective in blocking CA3-CA1-evoked synaptic transmission, excluding the involvement of mGluR2/3 subtypes at this developmental stage. 相似文献
996.
Recent interest in the neurotoxicity of haloperidol is based on its oxidation in rodents to the pyridinium derivative, HPP+, a structural analog of the neurotoxin, 1-methyl-4-phenylpyridinium (MPP+). Recently, we reported that HPP+ and a newly identified reduced pyridinium, RHPP+, were present in blood and urine of haloperidol-treated schizophrenics and that the concentrations of RHPP+ exceeded those of HPP+. In this study, we examined pathways for formation of RHPP+ in subcellular fractions of human liver (n=5) and brain (basal ganglia;n=5). The major pathway was reduction of HPP+ (20 µM) to RHPP+ in cytosol (0.17–0.39 and 0.03–0.07 µM RHPP+/g cytosolic protein per h in liver and brain, respectively). The reactions were inhibited significantly by menadione and in brain also by daunorubicin. The inhibition profile, cytosolic location and strict NADPH dependence suggest that the enzymes involved are ketone reductases. A second pathway was oxidation of reduced haloperidol (50 µM), a major metabolite of haloperidol in blood and brain, to RHPP+. In liver microsomes, 0.17–0.63 µmol RHPP+ was formed /g microsomal protein per h. A potent inhibitor of the pathway was ketoconazole (IC50, 0.8 µM), which suggests that P-450 3A isozymes could be involved. In brain mitochondria but not microsomes, reduced haloperidol (120 µM) was oxidised to RHPP+ at a small but significant rate (0.005–0.020 µmol RHPP+/g mitochondrial protein per h) which was not attenuated by SKF 525A, quinidine, ketoconazole, or monoamine oxidase inhibitors. Further studies are warranted to establish the biological importance of these metabolites in vivo. 相似文献
997.
Recent studies have shown that tetrafluoroethylene is a renal and hepatic carcinogen in the rat. In this study, we have examined
the ability of a single i.p. dose of 1,1,2,2-tetrafluoroethyl-l-cysteine (TFEC), a major metabolite of tetrafluoroethylene, to produce hepatic and renal injury in male and female rats.
We have also examined the effect of blocking the renal organic anion transport system with probenecid and of inhibiting the
activity of cysteine conjugate β-lyase with aminooxyacetic acid on the extent of renal injury produced by TFEC. Doses of ≥12.5 mg/kg
TFEC produced renal tubular necrosis to the pars recta of the proximal tubules within 24 h in both male and female rats. This
was associated with an increased kidney to body weight ratio and plasma urea at doses of ≥25 mg/kg. No consistent evidence
of liver injury was seen at doses up to 50 mg/kg TFEC in rats of either sex, although occasional vacuolation of hepatocytes
and a small dose-related increase in liver to body weight ratio was observed. Prior treatment of female rats with probenecid
completely prevented the renal injury produced by either 25 or 50 mg/kg TFEC as judged by plasma urea and histopathology.
However, prior treatment of female rats with aminooxyacetic acid afforded no protection against the nephrotoxicity produced
by either TFEC or the cysteine conjugate of hexachloro-1,3-butadiene. Thus no major sex difference in nephrotoxicity in the
rat was seen with TFEC, while accumulation of TFEC, or its N-acetyl derived metabolite, into renal proximal tubular cells
via a probenecid sensitive transport system appears to be a key event in the mechanism of nephrotoxicity. The lack of protection
observed with the cysteine conjugate β-lyase inhibitor, aminooxyacetic acid, may reflect the inability to completely inhibit
the mitochondrial form of this enzyme and thereby prevent the formation of the reactive metabolite. Our acute studies provide
no insight concerning the liver carcinogenicity of tetrafluoroethylene.
Received: 8 December 1997 / Accepted: 3 February 1998 相似文献
998.
A new method is presentd for the quantitative determination of regional blood volumes in vivo. It is based on rapid quantitative T1 mapping by Snapshot FLASH MRI combined with the injection of an intravascular MR contrast agent. Regional blood volumes in four different tissues of the rat (skeletal muscle, heart, liver, kidney) were determined in an In vivo experiment. 相似文献
999.
S. Iwamoto E. Kajii T. Omi T. Kamesaki Y. Akifuji S. Ikemoto 《European journal of haematology》1993,50(5):286-291
Abstract: A patient who represented acute hemolytic crisis was studied. Analysis of the erythrocyte membrane proteins by SDS-PAGE revealed a deficiency of band 4.2. In the family, the sister of the patient who had been clinically normal was also shown to be deficient in band 4.2. Binding studies showed that the propositus' membranes were able to bind normal band 4.2 protein as much as control. It was suggested that the binding sites for the protein were prepared on the membrane. We analyzed the band 4.2 cDNA of the propositus and detected a mutation that changes a codon for alanine to one for threonine at residue 142. Band 4.2 exon III of genomic DNA which included the mutation site was amplified and sequenced directly in the family members, and it was revealed that only the homozygotes of the mutation allele manifested band 4.2 deficiency and the parents, who were heterozygotes, showed normal amounts of band 4.2. Recently, the same mutation was reported as Protein 4.2NIPPON in another 4 cases (Bouhassira et al. Blood 1992: 79: 1846–1854). This study supports the hypothesis that this mutation is the pathogenetic cause of band 4.2 deficiency and not a polymorphism. 相似文献
1000.
Schmidt S.; Giessel R.; Bergis K. H.; Strojek K.; Grzeszczak W.; Ganten D.; Ritz E.; the Diabetic Nephropathy Study Group 《Nephrology, dialysis, transplantation》1996,11(9):1755-1761
BACKGROUND.: There is agreement that a family history of hypertension (HT),is a predictor for the risk of diabetic nephropathy (DN) inpatients with type 2 diabetes, and possibly also type 1 diabetes.It follows that genes related to the risk of hypertension mustalso be considered candidate genes for DN. The 235T allele ofthe angiotensinogen gene was found to be related to primaryHT. METHODS.: To examine whether it is predictive for DN as well, we examinedthe angiotensinogen gene polymorphism in 230 healthy local controls,423 patients with type 1 diabetes (n=180 with DN; n=243 withoutDN) and 663 patients with type 2 diabetes (n=310 with DN; n=353without DN). The angiotensinogen gene M235T polymorphism wasdetermined using PCR amplification. RESULTS.: The following results were obtained (i) no significant differenceof genotype distribution (type 1: MM/MT/TT(%) 27.6/57.2/15.2vs. 27.2/56.1/16.7 (P=0.92); type 2: MM/MT/TT (%) 31.7/48.2/20.1vs. 32.9/46.8/20.3 (P=0.93)) or allele frequencies (type 1:M 0.56 vs. 0.55 (P=0.795); type 2: M 0.56 vs. 0.56 (P=0.86))was found, between diabetic patients with or without DN, (ii)no difference was found between normotensive and hypertensivediabetic patients. CONCLUSION.: The data argue against a role of the angiotensinogen gene M235Tpolymorphism in the manifestation of diabetic nephropathy orhypertension in diabetic patients. 相似文献